Australia - English - Department of Health (Therapeutic Goods Administration)

strides pharma science pty ltd - oseltamivir phosphate, quantity: 39.4 mg - capsule, hard - excipient ingredients: pregelatinised maize starch; gelatin; titanium dioxide; purified talc; sodium stearylfumarate; purified water; iron oxide yellow; croscarmellose sodium; povidone; propylene glycol; butan-1-ol; isopropyl alcohol; ethanol; shellac; strong ammonia solution; potassium hydroxide; iron oxide black - oseltamivir str is indicated for the treatment of infections due to influenza a and b viruses in adults and children including full-term neonates. treatment should commence as soon as possible, but no later than 48 hours after the onset of the initial symptoms of infection.,oseltamivir str is indicated for the prevention of influenza in adults and children aged 1 year and older. vaccination is the preferred method of routine prophylaxis against infection with influenza virus.

Australia - English - Department of Health (Therapeutic Goods Administration)

strides pharma science pty ltd - oseltamivir phosphate, quantity: 98.5 mg - capsule, hard - excipient ingredients: gelatin; croscarmellose sodium; purified water; iron oxide yellow; titanium dioxide; sodium stearylfumarate; pregelatinised maize starch; purified talc; iron oxide red; povidone; sodium lauryl sulfate; propylene glycol; butan-1-ol; isopropyl alcohol; ethanol; shellac; strong ammonia solution; potassium hydroxide; iron oxide black - oseltamivir strides is indicated for the treatment of infections due to influenza a and b viruses in adults and children including full-term neonates. treatment should commence as soon as possible, but no later than 48 hours after the onset of the initial symptoms of infection.,oseltamivir strides is indicated for the prevention of influenza in adults and children aged 1 year and older. vaccination is the preferred method of routine prophylaxis against infection with influenza virus.

Australia - English - Department of Health (Therapeutic Goods Administration)

strides pharma science pty ltd - oseltamivir phosphate, quantity: 39.4 mg - capsule, hard - excipient ingredients: pregelatinised maize starch; purified talc; gelatin; povidone; croscarmellose sodium; iron oxide yellow; titanium dioxide; sodium stearylfumarate; purified water; propylene glycol; butan-1-ol; isopropyl alcohol; ethanol; shellac; strong ammonia solution; potassium hydroxide; iron oxide black - oseltamivir strides is indicated for the treatment of infections due to influenza a and b viruses in adults and children including full-term neonates. treatment should commence as soon as possible, but no later than 48 hours after the onset of the initial symptoms of infection.,oseltamivir strides is indicated for the prevention of influenza in adults and children aged 1 year and older. vaccination is the preferred method of routine prophylaxis against infection with influenza virus.

Australia - English - Department of Health (Therapeutic Goods Administration)

strides pharma science pty ltd - oseltamivir phosphate, quantity: 98.5 mg - capsule, hard - excipient ingredients: purified talc; gelatin; purified water; croscarmellose sodium; povidone; iron oxide red; sodium stearylfumarate; titanium dioxide; iron oxide yellow; pregelatinised maize starch; sodium lauryl sulfate; propylene glycol; butan-1-ol; isopropyl alcohol; ethanol; shellac; strong ammonia solution; potassium hydroxide; iron oxide black - oseltamivir str is indicated for the treatment of infections due to influenza a and b viruses in adults and children including full-term neonates. treatment should commence as soon as possible, but no later than 48 hours after the onset of the initial symptoms of infection.,oseltamivir str is indicated for the prevention of influenza in adults and children aged 1 year and older. vaccination is the preferred method of routine prophylaxis against infection with influenza virus.

Australia - English - Department of Health (Therapeutic Goods Administration)

strides pharma science pty ltd - oseltamivir phosphate, quantity: 59.1 mg - capsule, hard - excipient ingredients: pregelatinised maize starch; gelatin; titanium dioxide; povidone; purified water; croscarmellose sodium; purified talc; sodium stearylfumarate; propylene glycol; butan-1-ol; isopropyl alcohol; ethanol; shellac; strong ammonia solution; potassium hydroxide; iron oxide black - oseltamivir strides is indicated for the treatment of infections due to influenza a and b viruses in adults and children including full-term neonates. treatment should commence as soon as possible, but no later than 48 hours after the onset of the initial symptoms of infection.,oseltamivir strides is indicated for the prevention of influenza in adults and children aged 1 year and older. vaccination is the preferred method of routine prophylaxis against infection with influenza virus.

Australia - English - Department of Health (Therapeutic Goods Administration)

strides pharma science pty ltd - oseltamivir phosphate, quantity: 59.1 mg - capsule, hard - excipient ingredients: purified water; gelatin; iron oxide black; sodium stearylfumarate; croscarmellose sodium; pregelatinised maize starch; titanium dioxide; purified talc; povidone; propylene glycol; butan-1-ol; isopropyl alcohol; ethanol; shellac; strong ammonia solution; potassium hydroxide - oseltamivir str is indicated for the treatment of infections due to influenza a and b viruses in adults and children including full-term neonates. treatment should commence as soon as possible, but no later than 48 hours after the onset of the initial symptoms of infection.,oseltamivir str is indicated for the prevention of influenza in adults and children aged 1 year and older. vaccination is the preferred method of routine prophylaxis against infection with influenza virus.

United States - English - NLM (National Library of Medicine)

remedyrepack inc. - oseltamivir phosphate (unii: 4a3o49ngez) (oseltamivir acid - unii:k6106lv5q8) - oseltamivir carboxylate 75 mg - oseltamivir phosphate capsules, usp are indicated for the treatment of acute, uncomplicated illness due to influenza a and b infection in patients 2 weeks of age and older who have been symptomatic for no more than 48 hours. oseltamivir phosphate capsules, usp are indicated for the prophylaxis of influenza a and b in patients 1 year and older. - oseltamivir phosphate capsules, usp are not a substitute for early influenza vaccination on an annual basis as recommended by the centers for disease control and prevention advisory committee on immunization practices. - influenza viruses change over time. emergence of resistance substitutions could decrease drug effectiveness. other factors (for example, changes in viral virulence) might also diminish clinical benefit of antiviral drugs. prescribers should consider available information on influenza drug susceptibility patterns and treatment effects when deciding whether to use oseltamivir phosphate capsules, usp [ see microbiology (12.4) ] - oseltamivir phosphate c

Canada - English - Health Canada

accord healthcare inc - oseltamivir (oseltamivir phosphate) - capsule - 30mg - oseltamivir (oseltamivir phosphate) 30mg

Canada - English - Health Canada

accord healthcare inc - oseltamivir (oseltamivir phosphate) - capsule - 45mg - oseltamivir (oseltamivir phosphate) 45mg

Canada - English - Health Canada

accord healthcare inc - oseltamivir (oseltamivir phosphate) - capsule - 75mg - oseltamivir (oseltamivir phosphate) 75mg